General Chair

Yicheng Ni

Professor, Southeast University, China.

Research field: Image-guided Diagnosis and Treatment Integration, AI Medical Imaging, Tumor and Cancer Treatment, Medical Robots, Targeted Therapy, Medical Imaging, and Cancer Modeling.

Professor Yicheng Ni is a Changjiang Scholar Professor and Professor of Radiology at Zhongda Hospital Affiliated to Southeast University. He received his undergraduate and master's degrees from Nanjing Medical University and his doctorate from KU Leuven (a top 50 university globally) in Belgium in 1995. He was then exceptionally retained by KU Leuven and appointed as a tenured professor, founding and serving for many years as the director of the "Therapeutic Integration Laboratory" at KU Leuven until his honorable retirement in 2022. In 2023, Professor Ni was selected for the Ministry of Education's Changjiang Scholar Professor Program and became a full-time faculty member at Zhongda Hospital Affiliated to Southeast University. Professor Ni has long been dedicated to research in the field of medical imaging, conducting original research and clinical translation on major diseases threatening human health (such as cancer and cardiovascular diseases) based on image-guided navigation technology. He has led EU research projects and National Natural Science Foundation of China projects, published hundreds of SCI papers and monographs, holds more than ten international patents, and has received dozens of domestic and international awards. He is the only person in the world to have received both the Herbert M. Stauffer Award in medical imaging and the Elliott Lasser Award in contrast agents. He has been selected as one of the top 2% of scientists globally and ranked first in his special category by an internationally authoritative KOL (Key Opinion Leaders) organization. To date, Professor Ni has mentored dozens of postdoctoral fellows, doctoral students, and master's students, many of whom have become chief scientists, discipline leaders, or key personnel at renowned institutions both domestically and internationally, including Harvard University, Stanford University, Cambridge University, Zhejiang University, and Nanjing Medical University.

Nagy Habib

Professor, Imperial College London, UK.

Research field: Clinical Sciences, Oncology and Carcinogenesis, Public Health and Health Services, Paediatrics and Reproductive Medicine, Medical Biotechnology, Immunology.

Professor Nagy Habib is an academic surgeon and in July 2003 was awarded the position of professor of hepatobiliary surgery in the department of surgery and cancer, Faculty of Medicine, Imperial College London. He is director of the hepatopancreatobiliary (HPB) unit at Hammersmith Hospital, and in June 2007 was appointed a Pro Rector of Imperial College London and member of the College Management Board. Professor Nagy Habib pioneered the first clinical trial in the use of adenovirus for the treatment of liver cancer, as well as the use of plasmid gene therapy for hydrodynamic gene delivery. He is the first person in the West to publish a clinical trial on the use of autologous adult bone marrow-derived stem cells and RNA activation for the treatment of patients with liver insufficiency and liver cancer. He was selected as one of the top 10 surgeons in the UK by the Saturday Times Magazine and he was honoured to be elected to join the French Academy of Surgeons and the European Surgical Association. He held a gold award from the Advisory Committee for Clinical Excellencem, and the Winner of a Takreem Laureate award in 2012. He invented the Habib 4x liver resection device (acquired by AngioDynamics Inc 2015), and the Habib EndoHPB (won an Edison Gold award for Medical Innovation in 2020). He is the Founder of EMcision Ltd (medical device innovation), MiNA therapeutics (RNA therapeutics), Apterna (aptamer development), and Dawn Therapeutics (gene therapy). And he also elected Member of the French Académie Nationale de Chirurgie (2015). He has published more than 340 articles in scientific journals.

Pier Paolo Piccaluga

Associate Professor, University of Bologna, Italy.

Research field: Genomics of Hematological Malignancies, Metabolomics of Hematological Malignancies, Molecular Diagnostics, Digital pathology, Precision Medicine, Biobanking.

Pier Paolo Piccaluga is an Associate Professor of Pathology at the Department of Medical and Surgical Sciences at the Bologna University School of Medicine. He is also a co-founder and Executive Physician at the Biobank of Research, IRCCS S. Orsola-Malpighi Hospital in Italy. He has led the Molecular Hematopathology Laboratory for many years. In 2018, he was appointed to teach at Queen Mary University of London (UK) and Jomo Kenyatta University of Agriculture and Technology in Nairobi (Kenya), and since 2023, at the University of Nairobi and the University of Botswana. He is the author of several international publications indexed in the Current Contents (including Nature Medicine, Journal of Clinical Investigation, Journal of Experimental Medicine, Journal of Clinical Oncology, Blood, Lancet Oncology, and Lancet Infectious Diseases, with a total impact factor >1,000, a mean impact factor >6, and an H-index of 62 (ranked among the VIA-Academy Top Italian Scientists). He is the author of several presentations at national and international conferences. Dr. Piccaluga has participated in several clinical trials as a coordinator or sub-investigator and has won multiple awards for his contributions to study and research. He has served as a Principal Investigator (PI) in various research projects funded by nationally and internationally recognized organizations. He is the Editor-in-Chief of the World Journal of Hematology, Digital Medicine and Healthcare Technology, Advances in Precision Medicine, and the Journal of Cancer Biomoleculars and Therapeutics.

Organizing Committee Executive Chair

Ling Tao, Fudan University, China

Organizing Committee Member

Ahmed G. Hegazi, National Research Center, Egypt

Chun Zhou, Zhejiang University, China

Guodong Lu, Fudan University, China

Michael Thompson, University of Toronto, Canada

Shouhua Zhang, Jiangxi Provincial children's Hospital, China

Vladan Radosavljevic, Military Medical Academy, Serbia

Yuhan Chen, Seventh Medical Center, Chinese People's Liberation Army General Hospital, China

Zhenlan Du, Seventh Medical Center, Chinese People's Liberation Army General Hospital, China